Cohen Investment Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$555K Sell
3,635
-19
-0.5% -$2.91K 0.26% 58
2025
Q4
$504K Sell
3,654
-58
-2% -$7.59K 0.23% 61
2025
Q3
$476K Buy
3,712
+109
+3% +$13.3K 0.23% 62
2025
Q2
$436K Sell
3,603
-255
-7% -$28.7K 0.23% 61
2025
Q1
$430K Buy
3,858
+44
+1% +$4.68K 0.25% 66
2024
Q4
$371K Buy
3,814
+116
+3% +$12.4K 0.22% 70
2024
Q3
$425K Sell
3,698
-1,299
-26% -$147K 0.26% 63
2024
Q2
$509K Buy
4,997
+1,127
+29% +$113K 0.41% 49
2024
Q1
$374K Sell
3,870
-688
-15% -$70.5K 0.24% 64
2023
Q4
$460K Sell
4,558
-439
-9% -$42.4K 0.34% 53
2023
Q3
$509K Sell
4,997
-413
-8% -$41.9K 0.41% 49
2023
Q2
$546K Buy
5,410
+16
+0.3% +$1.6K 0.44% 52
2023
Q1
$496K Buy
5,394
+211
+4% +$18.4K 0.39% 58
2022
Q4
$470K Buy
5,183
+256
+5% +$21.6K 0.39% 57
2022
Q3
$375K Buy
4,927
+81
+2% +$6.71K 0.34% 62
2022
Q2
$410K Sell
4,846
-47
-1% -$4.12K 0.35% 63
2022
Q1
$429K Buy
4,893
+66
+1% +$5.71K 0.32% 66
2021
Q4
$422K Buy
4,827
+64
+1% +$5.31K 0.3% 64
2021
Q3
$390K Buy
4,763
+27
+0.6% +$2.43K 0.3% 65
2021
Q2
$432K Buy
4,736
+57
+1% +$5.08K 0.34% 60
2021
Q1
$400K Sell
4,679
-37
-0.8% -$3.32K 0.32% 66
2020
Q4
$445K Buy
+4,716
New +$412K 0.4% 51

Other funds holding NVS

Cohen Investment Advisors's NVS Position: Q1 2026 in Review

Cohen Investment Advisors reduced its Novartis (NVS) stake by 0.52% in Q1 2026, selling an estimated $2.91K and leaving 3,635 shares worth $555K. The position accounts for 0.26% of the portfolio, ranked #58.

Cohen Investment Advisors first reported a position in NVS in Q4 2020 and has held it in 22 quarters since. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Cohen Investment Advisors held 3,635 shares of Novartis worth $555K as of Q1 2026.
  • Cohen Investment Advisors sold 19 Novartis shares in Q1 2026, an estimated $2.91K.
  • Novartis made up 0.26% of Cohen Investment Advisors's portfolio in Q1 2026, its #58 holding.
  • Cohen Investment Advisors first reported a position in Novartis in Q4 2020 and has held it in 22 quarters since.
  • 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Cohen Investment Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.